insights_auto
Outlook: 57.6% bullish·4.5% bearish
Go to analysischevron_right
AMGN:NASDAQ
Amgen Inc
၄၆၅.၆၇ US$
arrow_downward
-၀.၃၀%(-၁.၃၉) 1D
နို ၁၃, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN...
Open
၄၆၇.၅၃ US$
High
၄၆၈.၀၀ US$
Low
၄၆၂.၂၂ US$
Mkt. cap
ဋေ ၂.၅၂ သ
Avg. vol.
၂.၇၃ သန်း
Volume
၀.၀၀
Dividend
၂.၁၆%
Quarterly dividend
၂.၅၂ US$
Ex-dividend date
၂၀၂၆ နို ၂၀
P/E ratio
၂၇.၀၀
52-wk high
၄၈၃.၉၉ US$
52-wk low
၃၁၂.၅၃ US$
EPS
၁၇.၂၅ US$
Beta
၀.၄၃
Shares outstanding
၅၄.၀၉ ကုဋေ
No. of employees
၃ သောင်း
Open
၄၆၇.၅၃ US$
High
၄၆၈.၀၀ US$
Low
၄၆၂.၂၂ US$
Mkt. cap
ဋေ ၂.၅၂ သ
Avg. vol.
၂.၇၃ သန်း
Volume
၀.၀၀
Dividend
၂.၁၆%
Quarterly dividend
၂.၅၂ US$
Ex-dividend date
၂၀၂၆ နို ၂၀
P/E ratio
၂၇.၀၀
52-wk high
၄၈၃.၉၉ US$
52-wk low
၃၁၂.၅၃ US$
EPS
၁၇.၂၅ US$
Beta
၀.၄၃
Shares outstanding
၅၄.၀၉ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
TradingKey
·
ပြီးခဲ့သည့် ၁ ရက်
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
The Motley Fool
·
ပြီးခဲ့သည့် ၁၁ နာရီ
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
BigGo Finance
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
StoneX
·
ပြီးခဲ့သည့် ၂ ရက်
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees၃.၁၅ သောင်း
Founded၁၉၈၀
Headquartersသောင်စင်အုက်စ်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websiteamgen.com